Search

Your search keyword '"Soriani, Marie-Hélène"' showing total 27 results

Search Constraints

Start Over You searched for: Author "Soriani, Marie-Hélène" Remove constraint Author: "Soriani, Marie-Hélène"
27 results on '"Soriani, Marie-Hélène"'

Search Results

1. Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition

2. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

4. Reply to the letter from Gazulla

5. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

9. A phase II−III trial of olesoxime in subjects with amyotrophic lateral sclerosis

10. Technology Brain Computer Interface for Autonomy: Patient-adapted ergonomic headset for dry-EEG P300 speller

12. Single‐fiber studies for assigning pathogenicity of eight mitochondrial DNA variants associated with mitochondrial diseases

13. Implanted Phrenic Stimulation Impairs Local Diaphragm Myofiber Reinnervation in Amyotrophic Lateral Sclerosis

14. ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis

15. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

17. CHCHD10mutations are not a common cause ofSMN1-negative type III/IV spinal motor atrophy

19. HNPP et/ou polyradiculonévrite ?

20. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

21. Reply to the letter from Gazulla et al.

23. Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: A French national survey

24. Safety of home parenteral nutrition in patients with amyotrophic lateral sclerosis: A French national survey.

25. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

26. [Management of amyotrophic lateral sclerosis].

27. [Chronic sarcoid myositis].

Catalog

Books, media, physical & digital resources